Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Claudin18.2-Targeted Car-Dcs
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Claudin18.2-Targeted Car-T Cells
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Clbr001
Breast Cancer
Calibr, a division of Scripps Research
P1
CC
(43)
Clbr001
HER2 Positive Breast Carcinoma
Calibr, a division of Scripps Research
P1
CC
(43)
Clbr001
Hormone Receptor-Positive Breast Cancer
Calibr, a division of Scripps Research
P1
CC
(43)
Clic-2201
B-Cell Acute Lymphoblastic Leukemia
British Columbia Cancer Agency
P1
CC
(43)
Cln-049
Myelodysplastic Syndrome
Cullinan Therapeutics Inc.
P1
CC
(43)
Cln-049
Acute Myeloid Leukemia
Cullinan Therapeutics Inc.
P1
CC
(43)
Cln-978
Non-Hodgkin Lymphoma
Cullinan Therapeutics Inc.
P1
CC
(43)
Clonidine
Essential Hypertension
University of Kansas Medical Center
P1
CC
(43)
Clostridium Butyricum Miyairi 588
Papillary Renal Cell Carcinoma
City of Hope Medical Center
P1
CC
(43)
Clostridium Novyi-Nt
Breast Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Digestive System Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Female Reproductive Organ Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Head And Neck Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Male Reproductive Organ Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Malignant Mesothelioma
M.D. Anderson Cancer Center
P1
CC
(43)
Clostridium Novyi-Nt
Malignant Endocrine Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Cmab017
Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd
P1
CC
(43)
Cnty-101
Non-Hodgkin Lymphoma
Century Therapeutics, Inc.
P1
CC
(43)
Cobicistat
Pancreatic Ductal Adenocarcinoma
German Cancer Research Center
P1
CC
(43)
Cobimetinib
Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cobimetinib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Showing 1676 to 1700 of 9,928 assets
Previous
Page 68 of 398
Next
